Abeona Therapeutics Inc. (NASDAQ: ABEO) trades at approximately $6.16 per share. The micro-cap biotechnology equity fluctuates dynamically based on clinical trial updates, commercial launch milestones, regulatory announcements, and overall micro-cap healthcare sector trading sentiment on the Nasdaq exchange.